Criminal or bystander: imatinib and second primary malignancy in GIST patients

被引：8
|
作者：
Kanda, Tatsuo [1 ]
机构：
[1] Sanjo Gen Hosp, Sanjo City, Niigata 9550055, Japan
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2013年 / 25卷 / 05期
关键词：
GASTROINTESTINAL STROMAL TUMORS; NEOPLASMS; COEXISTENCE; KIT;
D O I：
10.3978/j.issn.1000-9604.2013.10.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 492
页数：3
相关论文
共 50 条
  • [1] Criminal or bystander: imatinib and second primary malignancy in GIST patients
    Tatsuo Kanda
    ChineseJournalofCancerResearch, 2013, 25 (05) : 490 - 492
  • [2] Second primary malignances (SPMs) in patients with gastrointestinal stromal tumors (GIST): The potential influence of imatinib treatment.
    Estival, Anna
    Espasa, Laia
    Etxaniz, Olatz
    Blanco, Ignacio
    Luis Cuadra-Urteaga, Jose
    de los Llanos Gil, Maria
    Balana, Carmen
    Ojanguren, Isabel
    Indacochea, Alberto
    Ahial, Sara
    Vila, Laia
    Carcereny, Enric
    Mijangos, Erika
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] The role of neoadjuvant imatinib therapy of patients with primary locally advanced GIST
    Arkhiri, P.
    Poddubnaya, I.
    Nered, S.
    Bokhian, V. Y.
    Peregorodiev, I.
    Nikulin, M. P.
    Stilidi, I. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] The role of neoadjuvant imatinib therapy of patients with primary locally advanced GIST.
    Arkhiri, Peter
    Poddubnaya, Irina
    Nered, Sergey N.
    Peregorodiev, Ivan N.
    Nikulin, Maxim P.
    Stilidi, Ivan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] The role and optimal duration of adjuvant imatinib therapy in primary GIST patients.
    Arkhiri, Peter
    Stilidi, Ivan S.
    Poddubnaya, Irina
    Nered, Sergey N.
    Bokhian, Vahan Yurikovich
    Peregorodiev, Ivan N.
    Nikulin, Maxim P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] SECOND PRIMARY MALIGNANCY IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
    Polverelli, N.
    Elli, E.
    Abruzzese, E.
    Palumbo, G. A.
    Benevolo, G.
    Breccia, M.
    Tiribelli, M.
    Bonifacio, M.
    Tieghi, A.
    Martino, B.
    Sgherza, N.
    D'Adda, M.
    Bergamaschi, M.
    Crugnola, M.
    Cavazzini, F.
    Bosi, C.
    Binotto, G.
    Isidori, A.
    Bartoletti, D.
    Auteri, G.
    Latagliata, R.
    Gandolfi, L.
    Scaffidi, L.
    Cattaneo, D.
    Codeluppi, K.
    Trawinska, M.
    Griguolo, D.
    Cuneo, A.
    Krampera, M.
    Semenzato, G.
    Di Raimondo, F.
    Lemoli, R. M.
    Cavo, M.
    Vianelli, N.
    Russo, D.
    Iurlo, A.
    Palandri, F.
    HAEMATOLOGICA, 2019, 104 : 3 - 3
  • [7] SECOND PRIMARY MALIGNANCY IN HEMATOLOGY PATIENTS IS A RARE ENTITY?
    Palla, K.
    Kolovou, A.
    Tsirakis, G.
    Pantieras, N.
    HAEMATOLOGICA, 2013, 98 : 759 - 759
  • [8] Observations of Second Primary Malignancy in Patients With Multiple Myeloma
    Ormerod, Anne
    Fausel, Christopher A.
    Abonour, Rafat
    Kiel, Patrick J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (02): : 113 - 117
  • [9] Second Primary Malignancy Among Pancreatic Cancer Patients
    Luketina, R.
    Michalski, C. W.
    Tjaden, C.
    Buechler, M. W.
    Hackert, T.
    PANCREAS, 2015, 44 (08) : 1394 - 1394
  • [10] Second primary malignancy in myelofibrosis patients treated with ruxolitinib
    Polverelli, Nicola
    Elli, Elena M.
    Abruzzese, Elisabetta
    Palumbo, Giuseppe A.
    Benevolo, Giulia
    Tiribelli, Mario
    Bonifacio, Massimiliano
    Tieghi, Alessia
    Caocci, Giovanni
    D'Adda, Mariella
    Bergamaschi, Micaela
    Binotto, Gianni
    Heidel, Florian H.
    Cavazzini, Francesco
    Crugnola, Monica
    Pugliese, Novella
    Bosi, Costanza
    Isidori, Alessandro
    Bartoletti, Daniela
    Auteri, Giuseppe
    Latagliata, Roberto
    Gandolfi, Lisa
    Martino, Bruno
    Scaffidi, Luigi
    Cattaneo, Daniele
    D'Amore, Fabio
    Trawinska, Malgorzata M.
    Stella, Rossella
    Markovic, Uros
    Catani, Lucia
    Pane, Fabrizio
    Cuneo, Antonio
    Krampera, Mauro
    Semenzato, Gianpietro
    Lemoli, Roberto M.
    Vianelli, Nicola
    Breccia, Massimo
    Russo, Domenico
    Cavo, Michele
    Iurlo, Alessandra
    Palandri, Francesca
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 356 - 368
12345